Clinical Features of Diabetes

Slide 1 · Clinical Features of Diabetes

Patterns of presentation, metabolic emergencies, and long-term clinical consequences

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Contrast common initial presentations of type 1 and type 2 diabetes.

Derive polyuria, polydipsia, polyphagia, and weight loss from insulin deficiency.

Recognize clinical patterns of ketoacidosis, hyperosmolar hyperglycemia, and hypoglycemia.

Connect chronic vascular injury with characteristic organ manifestations.

Slide 3 · Clinical diabetes has several entry points

Symptomatic hyperglycemia

Incidental laboratory detection

Acute metabolic crisis

Long-term organ injury

Clinical phenotype reflects metabolic severity, pace of onset, and accumulated tissue damage.

Slide 4 · Two major subtypes—different first encounters

Type 1 diabetes

Autoimmune β-cell loss

Often symptomatic near overt onset

Can present with ketoacidosis

Type 2 diabetes

Insulin resistance plus β-cell dysfunction

Often detected while asymptomatic

Chronic effects may precede recognition

Slide 5 · Type 1 diabetes can present at any age

The label “juvenile-onset diabetes” is misleading.

Autoimmune β-cell destruction can occur in childhood or adulthood.

The rate of residual insulin loss determines clinical tempo.

Age alone does not establish diabetes subtype.

Slide 6 · Type 1 diabetes: Silent loss, then overt disease

Progressive β-cell destruction

Falling insulin reserve

Increased metabolic demand

Overt symptomatic diabetes

Biologic decline is gradual; Clinical transition may appear abrupt.

Slide 7 · Why a gradual disease may seem sudden

Residual β-cell secretion compensates until a functional threshold is crossed.

The final transition from dysglycemia to overt diabetes may be rapid.

Clinical onset therefore does not identify the beginning of autoimmunity.

New symptoms should prompt assessment of metabolic decompensation.

Slide 8 · Intercurrent infection can expose insulin deficiency

Infection or another stress

Higher insulin requirement

Inadequate β-cell reserve

Symptomatic hyperglycemia

A precipitating illness may reveal previously unrecognized type 1 diabetes.

Slide 9 · The type 1 “honeymoon period”

Shortly after diagnosis, some endogenous insulin secretion persists.

Insulin requirement may be low during the first 1–2 years.

The period is temporary: Residual β-cell function continues to decline.

Reduced insulin dose does not mean that autoimmune diabetes has resolved.

Slide 10 · Early remission is not reversal of disease

Observed during honeymoon

Lower exogenous insulin requirement

Residual endogenous insulin output

Improved early metabolic stability

Underlying trajectory

Progressive β-cell loss persists

Absolute deficiency eventually dominates

Insulin requirement often rises substantially

Slide 11 · The classic triad of type 1 diabetes

Marked insulin deficiency

Polyuria

Polydipsia

Polyphagia

Catabolism commonly produces weight loss and weakness despite increased appetite.

Slide 12 · How insulin deficiency produces hyperglycemia

Reduced glucose uptake in muscle/adipose

Increased hepatic glucose output

Plasma hyperglycemia

Counterregulatory hormones, particularly glucagon, aggravate the imbalance.

Slide 13 · Glycosuria occurs when reabsorption is exceeded

High plasma glucose

Increased filtered glucose load

Tubular reabsorption overwhelmed

Glucose appears in urine

This renal event initiates osmotic water loss.

Slide 14 · Polyuria: The osmotic-diuresis mechanism

Glycosuria

Osmotic retention of tubular water

Increased urine volume

Water and electrolyte depletion

Polyuria is a mechanistic consequence of sustained marked hyperglycemia.

Slide 15 · Polydipsia is the response to fluid depletion

Osmotic diuresis

Water deficit + hyperosmolarity

Thirst-centre activation

Intense thirst

Hyperosmolarity also draws water from intracellular compartments.

Slide 16 · Why appetite rises despite hyperglycemia

Insulin deficiency

Protein and fat breakdown

Net negative energy balance

Polyphagia

Circulating glucose is abundant, but insulin-dependent anabolic use is impaired.

Slide 17 · Why diabetes may cause weight loss

Low effective insulin action

Proteolysis + lipolysis

Loss of body tissue stores

Weight loss / weakness

The coexistence of increased appetite and weight loss is diagnostically important.

Slide 18 · Polyphagia with weight loss is a warning pattern

History

Increased appetite

Unintentional weight loss

Thirst and frequent urination

Pathophysiologic interpretation

Anabolic signaling inadequate

Catabolism predominates

Hyperglycemia with osmotic diuresis

Slide 19 · A targeted history for symptomatic diabetes

Ask specifically about increased urine output and thirst.

Establish appetite change and unintended weight loss.

Ask about fatigue, muscle weakness, and blurred vision.

Assess recent infection or other stress before acute deterioration.

Slide 20 · Type 1 severity is not captured by glucose alone

Water loss can cause clinically important volume depletion.

Catabolism explains muscle weakness and ongoing weight loss.

Insulin absence creates the metabolic setting for ketogenesis.

Nausea, vomiting, labored breathing, or mental-status change suggest crisis.

Slide 21 · Type 2 diabetes: A common clinical setting

Classically recognized in adults over 40 years with obesity.

Type 2 diabetes is also increasingly diagnosed in younger people.

Increasing childhood obesity and sedentary behavior contribute.

Age and body habitus suggest risk but are not definitive classification tests.

Slide 22 · Type 2 diabetes may develop with few symptoms

Insulin resistance

Inadequate β-cell compensation

Persistent hyperglycemia

Detection on routine testing

The most frequent diagnosis pathway is incidental blood testing.

Slide 23 · Type 2 diabetes: Symptoms when present

Unexplained fatigue can prompt a clinical visit.

Dizziness is a possible nonspecific complaint.

Blurred vision can accompany hyperglycemia.

Absence of classic symptoms does not exclude diabetes.

Slide 24 · Overt symptoms versus incidental diagnosis

Symptom-driven evaluation

Thirst, urination, appetite changes

Weight loss or fatigue

Possible acute decompensation

Laboratory-driven diagnosis

No volunteered symptoms

Unexpected elevated glucose/HbA1c

Requires deliberate clinical follow-up

Slide 25 · Risk clues for recognizing silent type 2 diabetes

Obesity or an adverse metabolic phenotype.

A family history of diabetes.

Metabolic syndrome or associated cardiometabolic risk.

Older age is relevant, but type 2 diabetes also occurs in youth.

Slide 26 · Diabetes may be clinically silent

Unrecognized hyperglycemia

No classic symptoms

Routine testing detects disease

Long-term injury may accumulate

Symptoms are an unreliable gatekeeper for identifying type 2 diabetes.

Slide 27 · Compare typical type 1 and type 2 presentations

Feature

Type 1 diabetes

Type 2 diabetes

Onset

Often conspicuous

Frequently clinically silent

Age

Any age

Often adult; Also youth

Core defect

β-cell destruction

Resistance + secretory failure

Ketosis

Higher risk

Less common; Possible with stress

Diagnostic route

Symptoms / crisis

Often routine testing

Slide 28 · Clinical phenotype is not a substitute for classification

Older age does not rule out autoimmune type 1 diabetes.

Obesity does not by itself prove type 2 diabetes.

Other forms of diabetes can require insulin.

Clinical context should be interpreted alongside etiologic assessment.

Slide 29 · Slowly progressive autoimmune diabetes in adults

Latent autoimmune diabetes in adults (LADA) occurs in adulthood.

Its course may initially resemble type 2 diabetes.

Diabetes-associated autoantibodies support autoimmune etiology.

Many patients ultimately require insulin, even if not initially.

Slide 30 · Clinical assessment of a possible new diagnosis

Symptoms or incidental hyperglycemia

Evaluate metabolic stability

Confirm hyperglycemia by appropriate test

Assess clinical subtype

Acute deterioration and marked dehydration require priority assessment.

Slide 31 · Laboratory routes to diagnosing diabetes

Test

Textbook diagnostic threshold

Fasting plasma glucose

≥126 mg/dL

Random plasma glucose + classic symptoms

≥200 mg/dL

2-h plasma glucose after 75-g OGTT

≥200 mg/dL

HbA1c

≥6.5%

Slide 32 · When confirmation of hyperglycemia matters

The text recommends repeat confirmation for most diagnostic tests.

Exception: Classic hyperglycemic symptoms with qualifying random glucose.

Serious illness may cause transient stress hyperglycemia.

Reassess persistence after the acute illness has resolved.

Slide 33 · HbA1c and plasma glucose answer different questions

Plasma glucose

Measurement at the testing time

Sensitive to recent metabolic fluctuations

Especially useful in overt symptomatic hyperglycemia

HbA1c

Glycation reflects preceding weeks–months

Less influenced by day-to-day fluctuation

Supports diagnosis and longer-term control assessment

Slide 34 · Three acute clinical patterns to recognize

Altered glucose homeostasis

Diabetic ketoacidosis

Hyperosmolar hyperglycemic state

Treatment-associated hypoglycemia

These syndromes differ in mechanism, but each can impair consciousness.

Slide 35 · Diabetic ketoacidosis: Common triggers

An omitted or inadequate insulin dose is a frequent precipitant.

Infection and intercurrent illness increase insulin needs.

Trauma and certain medications can be additional stressors.

DKA is typical of type 1 diabetes but possible in type 2 diabetes.

Slide 36 · DKA reflects combined insulin lack and glucagon excess

Insulin deficiency + glucagon excess

Increased hepatic glucose production

Severe hyperglycemia

Osmotic diuresis / dehydration

Impaired peripheral glucose utilization further intensifies hyperglycemia.

Slide 37 · Ketone production in diabetic ketoacidosis

Insulin deficiency

Adipose lipolysis

Free fatty acids delivered to liver

Ketone-body synthesis

Major ketone bodies include acetoacetate and β-hydroxybutyrate.

Slide 38 · Why ketosis becomes ketoacidosis

Accelerated hepatic ketogenesis

Ketone production exceeds utilization

Ketone accumulation

Metabolic acidosis

Dehydration may compromise urinary ketone excretion and aggravate the disturbance.

Slide 39 · Clinical clues to diabetic ketoacidosis

Fatigue with nausea and vomiting.

Abdominal pain may be severe.

Fruity breath odor and deep, labored respiration.

Mental status may deteriorate as the crisis persists.

Slide 40 · Kussmaul breathing is a metabolic clue

Ketone-associated acidosis

Respiratory compensatory response

Deep, labored breathing

Concern for DKA

Do not interpret the breathing pattern as an isolated respiratory diagnosis.

Slide 41 · Neurologic deterioration in ketoacidosis

Persisting dehydration and metabolic disturbance can impair consciousness.

Depressed alertness may progress to coma.

Severe DKA is a medical emergency requiring urgent evaluation.

The precipitating illness remains clinically important.

Slide 42 · DKA is not exclusive to type 1 diabetes

Severe stress may provoke ketoacidosis in type 2 diabetes.

Serious infections and trauma are examples in the source.

The clinical syndrome should be recognized before assuming subtype.

Risk depends on effective insulin availability in the stress state.

Slide 43 · Hyperosmolar hyperglycemic state: Water deficit dominates

Sustained marked hyperglycemia

Prolonged osmotic diuresis

Insufficient water replacement

Severe dehydration / hyperosmolarity

Residual insulin often restrains unrestricted ketogenesis.

Slide 44 · Hyperosmolar state: Clinical setting

Often described in an older person with type 2 diabetes.

Stroke, infection, or disability may prevent adequate fluid intake.

Severe dehydration develops as urinary water loss continues.

Altered mental status can be the presenting feature.

Slide 45 · Why hyperosmolar presentation can be delayed

Often absent or less prominent

Marked ketoacidosis

Kussmaul breathing

Ketotic nausea and vomiting

May become prominent late

Prolonged water deficit

Severe hyperglycemia

Depressed mental status

Slide 46 · Clinical contrast: Ketoacidosis versus hyperosmolar state

Pattern

DKA

HHS

Predominant metabolic problem

Ketosis + acidosis

Hyperosmolar water depletion

Typical association

Type 1 diabetes

Type 2 diabetes

Respiratory clue

Kussmaul breathing

Usually no ketotic breathing

GI symptoms

Nausea / pain may occur

May be absent

Consciousness

May be impaired

Often impaired with severe dehydration

Slide 47 · Treatment-associated hypoglycemia

Most relevant during insulin therapy in either major subtype.

Sulfonylurea therapy in type 2 diabetes is another cause.

The problem reflects excessive glucose-lowering action relative to need.

Prompt recognition is essential because brain function can deteriorate.

Slide 48 · Common precipitants of hypoglycemia

Glucose availability < treatment effect

Missed meal

Excessive exertion

Excessive or incorrect dose

Evaluate the relationship among medication, nutritional intake, and activity.

Slide 49 · Hypoglycemia: Autonomic and neurologic features

Warning / adrenergic features

Sweating

Palpitations

Tachycardia

Neuroglycopenic features

Dizziness or confusion

Reduced consciousness

Possible loss of consciousness

Slide 50 · Hypoglycemia unawareness

Repeated episodes may blunt recognizable early warning features.

Neurologic impairment can become the first evident symptom.

The patient may have little opportunity for self-correction.

Repeated severe episodes require urgent review of therapy and risk.

Slide 51 · Approach to acute altered consciousness in diabetes

Altered mental status

Prompt bedside glucose assessment

Recognize low versus high glucose context

Urgent syndrome-directed care

Hypoglycemia, DKA, and HHS must not be clinically conflated.

Slide 52 · Chronic complications: Two vascular compartments

Macrovascular disease

Large and medium arteries

Accelerated atherosclerosis

Coronary, cerebral, peripheral ischemia

Microvascular disease

Small-vessel dysfunction / injury

Retinal, renal, neural involvement

Progressive end-organ impairment

Slide 53 · Clinical consequences of macrovascular diabetes

Chronic vascular risk

Accelerated atherosclerosis

Cardiac / cerebral / limb ischemia

Common clinical events include myocardial infarction, stroke, and lower-extremity ischemia.

Slide 54 · Three major microvascular targets

Diabetic microvascular injury

Retina → visual disease

Kidney → nephropathy

Peripheral nerve → neuropathy

Organ-specific manifestations can arise after prolonged hyperglycemia.

Slide 55 · Nephropathy may begin without symptoms

Chronic renal microvascular injury

Urinary albumin leakage

Progressive renal dysfunction

Possible kidney failure

Urinary albumin excretion may reveal renal injury before overt symptoms.

Slide 56 · What brings ocular diabetes to attention?

Blurred vision can occur with hyperglycemia early in diabetes.

Long-standing diabetes may produce retinopathy.

The source links retinal neovascularization to VEGF expression during hypoxia.

Cataract and glaucoma also contribute to visual impairment.

Slide 57 · Distal symmetric diabetic polyneuropathy

Peripheral nerve injury

Distal lower-limb dysfunction

Symmetric sensory / motor symptoms

Possible hand involvement

Advanced distribution may resemble a stocking-and-glove pattern.

Slide 58 · Autonomic neuropathy: Clinical manifestations

Disorders of bowel function.

Bladder dysfunction.

Erectile dysfunction may occur.

Symptoms reflect autonomic—not only sensory—nerve involvement.

Slide 59 · Focal diabetic neuropathy can appear abruptly

A mononeuropathy may produce footdrop.

Wrist-drop is another recognized presentation.

Isolated cranial nerve palsies may occur.

A focal neurological presentation requires appropriate differential assessment.

Slide 60 · Why infections may be more consequential

Impaired host-cell function

Vascular compromise

Reduced local defense

Greater infection susceptibility

Altered neutrophil function and impaired macrophage responses.

Slide 61 · Neuropathy and foot infection can amplify each other

Peripheral sensory deficit

Unrecognized minor injury

Local infection

Gangrene / systemic spread

A small toe lesion can initiate a clinically serious sequence in high-risk patients.

Slide 62 · Long duration increases cumulative injury

Severity and duration of hyperglycemia correlate with chronic complications.

End-organ disease often evolves over many years.

Glycemic control reduces risk but does not remove all risk.

Obesity, insulin resistance, and cardiovascular comorbidities matter as well.

Slide 63 · Glucose measures: Symptoms versus cumulative exposure

Single glucose observation

Useful for current metabolic state

Essential in acute symptomatic evaluation

May vary across hours and days

Longitudinal glycemic burden

HbA1c reflects longer exposure

Sustained dysglycemia drives tissue injury

Time in range adds temporal information

Slide 64 · Case 1: Abrupt symptomatic presentation

Clinical vignette (hypothetical)

An adolescent reports excessive urination, intense thirst, increased appetite, and unintentional weight loss after a febrile illness.

Which pathophysiologic sequence best unifies these findings?

Slide 65 · Case 1: Mechanism-based interpretation

Progressive insulin deficiency can become clinically apparent under stress.

Hyperglycemia leads to glycosuria and osmotic diuresis.

Fluid depletion and hyperosmolarity stimulate thirst.

Protein and fat catabolism produce weight loss despite hunger.

Slide 66 · Case 2: Asymptomatic detection

Clinical vignette (hypothetical)

A middle-aged adult with obesity and a family history of diabetes feels generally well; An elevated plasma glucose is found at a routine visit.

What is the most appropriate clinical interpretation of the presentation?

Slide 67 · Case 2: Interpretation and next step

Type 2 diabetes is frequently detected by laboratory testing before classic symptoms emerge.

Clinical silence does not exclude persistent hyperglycemia.

Confirm the abnormality with an appropriate diagnostic strategy.

Consider metabolic context without using obesity as a definitive subtype test.

Slide 68 · Case 3: Acute abdominal and respiratory symptoms

Clinical vignette (hypothetical)

A person with diabetes misses insulin during an infection and develops nausea, abdominal pain, fruity breath, and deep labored respirations.

Which acute complication should be suspected immediately?

Slide 69 · Case 3: Recognize diabetic ketoacidosis

Insulin deficiency during stress favors simultaneous hyperglycemia and ketogenesis.

Lipolysis supplies free fatty acids for hepatic ketone production.

Ketone accumulation produces metabolic acidosis.

Kussmaul breathing and abdominal symptoms are red flags.

Slide 70 · Case 4: Sudden confusion during glucose-lowering therapy

Clinical vignette (hypothetical)

A treated patient becomes sweaty, tachycardic, and confused after missing a meal.

Which reversible complication must be checked first?

Slide 71 · Case 4: Recognize hypoglycemia

The symptom combination is consistent with treatment-associated hypoglycemia.

Missing food can increase the glucose-lowering effect of medication.

Sweating and palpitations may precede neuroglycopenia.

Immediate glucose assessment and prompt correction are critical.

Slide 72 · Clinical synthesis: Match the pattern to the mechanism

Clinical presentation

Triad + weight loss → catabolism

Silent hyperglycemia → screening

Acidosis / dehydration → crisis

Organ injury → chronic disease

Clinical findings make sense when traced back to insulin availability, glycemic burden, and vascular injury.

Slide 73 · Core clinical conclusions

Type 1 diabetes may be abrupt clinically despite gradual β-cell loss.

Type 2 diabetes is often silent and found incidentally.

Polyuria, thirst, increased appetite, and weight loss have distinct metabolic mechanisms.

Acute crises and long-term complications must be recognized as different clinical pathways.

Slide 74 · Suggested source reading

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th ed. Chapter 24, The Endocrine System.

Sections used for this clinical lecture

Clinical Features of Diabetes

The Classic Triad of Type 1 Diabetes

Acute Metabolic Complications of Diabetes

Chronic Complications of Diabetes

Clinical Manifestations of Chronic Diabetes